Arbutus Biopharma Corporation
ABUS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$70 | -$73 | -$69 | -$76 |
| Dep. & Amort. | $1 | $1 | $1 | $2 |
| Deferred Tax | $0 | $0 | $0 | -$8 |
| Stock-Based Comp. | $9 | $9 | $7 | $6 |
| Change in WC | -$3 | -$18 | $29 | $1 |
| Other Non-Cash | -$2 | -$6 | -$4 | $8 |
| Operating Cash Flow | -$65 | -$86 | -$35 | -$68 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $2 |
| Inv. Purchases | -$142 | -$81 | -$130 | -$82 |
| Inv. Sales/Matur. | $165 | $132 | $56 | $70 |
| Other Inv. Act. | $0 | $0 | $0 | -$2 |
| Investing Cash Flow | $23 | $51 | -$75 | -$13 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $44 | $30 | $20 | $135 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$12 |
| Other Fin. Act. | $8 | $1 | $11 | $15 |
| Financing Cash Flow | $52 | $31 | $32 | $137 |
| Forex Effect | -$0 | $0 | -$0 | $0 |
| Net Chg. in Cash | $10 | -$4 | -$79 | $57 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $26 | $31 | $109 | $52 |
| End Cash | $36 | $26 | $31 | $109 |
| Free Cash Flow | -$65 | -$87 | -$36 | -$68 |